S165F mutation of junctophilin 2 affects Ca2+ signalling in skeletal muscle

Biochemical Journal

Volumn 427, Issue 1, 2010, Pages 125-134

  Woo, Jin Seok ^a   Hwang, Ji Hye ^a   Ko, Jae Kyun ^b   Weisleder, Noah ^b   Kim, Do Han ^c   Ma, Jianjie ^b   Lee, Eun Hui ^a  

^a The Catholic University of Korea   (South Korea)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Ca2+ homoeostasis; Junctional membrane complex; Junctophilin 2; Muscle hypertrophy; Protein kinase C (PKC); Transient receptor potential cation canonical type channel 3 (TRPC3)

Indexed keywords

CA2+ HOMOEOSTASIS; HOMOEOSTASIS; JUNCTIONAL MEMBRANE COMPLEX; PROTEIN KINASE C; TRANSIENT RECEPTOR POTENTIALS;

BODY FLUIDS; CALCIUM; MEMBRANES; PATHOLOGY; PHOSPHORYLATION; POSITIVE IONS; PROTEINS;

MUSCLE;

CALCIUM; CALCIUM CHANNEL; JUNCTOPHILIN 2; MEMBRANE PROTEIN; PROTEIN KINASE C; RYANODINE RECEPTOR 1; SERINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; UNCLASSIFIED DRUG; CAFFEINE; JUNCTOPHILIN; PHOSPHODIESTERASE INHIBITOR; RYANODINE RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; EXCITATION CONTRACTION COUPLING; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; MOUSE; MUSCLE FUNCTION; MUTATION; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSVERSE TUBULAR SYSTEM; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; GENETICS; HUMAN; IMMUNOBLOTTING; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CAFFEINE; CALCIUM SIGNALING; CELLS, CULTURED; CYTOSOL; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUTATION; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PROTEIN KINASE C; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS;

EID: 77950902596     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20091225     Document Type: Article

References (43)

1. Brady, A. J. (1964) Excitation and excitation-contraction coupling in cardiac muscle. Annu. Rev. Physiol. 26, 341-356
2. Sandow, A. (1965) Excitation-contraction coupling in skeletal muscle. Pharmacol. Rev. 17, 265-320
3. Lee, E. H., Kim, D. H. and Allen, P. D. (2006) Interplay between intra- and extracellular calcium ions. Mol. Cells 21, 315-329
4. Lee, E. H., Cherednichenko, G., Pessah, I. N. and Allen, P. D. (2006) Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. J. Biol. Chem. 281, 10042-10048
5. Woo, J. S., Kim, D. H., Allen, P. D. and Lee, E. H. (2008) TRPC3-interacting triadic proteins in skeletal muscle. Biochem. J. 411, 399-405
6. Abramowitz, J. and Birnbaumer, L. (2009) Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J. 23, 297-328
7. Takeshima, H., Komazaki, S., Nishi, M., Iino, M. and Kangawa, K. (2000) Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell 6, 11-22
8. Ito, K., Komazaki, S., Sasamoto, K., Yoshida, M., Nishi, M., Kitamura, K. and Takeshima, H. (2001) Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. J. Cell Biol. 154, 1059-1067 (Pubitemid 34286184)
9. 2+ release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes. Pharmacol. Ther. 121, 265-272
10. Nishi, M., Mizushima, A., Nakagawara, K. and Takeshima, H. (2000) Characterization of human junctophilin subtype genes. Biochem. Biophys. Res. Commun. 273, 920-927
11. Nishi, M., Sakagami, H., Komazaki, S., Kondo, H. and Takeshima, H. (2003) Coexpression of junctophilin type 3 and type 4 in brain. Mol. Brain Res. 118, 102-110
12. Komazaki, S., Nishi, M. and Takeshima, H. (2003) Abnormal junctional membrane structures in cardiac myocytes expressing ectopic junctophilin type 1. FEBS Lett. 542, 69-73
13. Woo, J. S., Hwang, J. H., Ko, J. K., Kim, D. H., Ma, J. and Lee, E. H. (2009) Glutamate at position 227 of junctophilin-2 is involved in binding to TRPC3. Mol. Cell. Biochem. 328, 25-32
14. 2+ release from sarcoplasmic reticulum through silencing of junctophilin genes. Biophys. J. 90, 4418-4427
15. Maron, B. J. (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA, J. Am. Med. Assoc. 287, 1308-1320
16. Minamisawa, S., Oshikawa, J., Takeshima, H., Hoshijima, M., Wang, Y., Chien, K. R., Ishikawa, Y. and Matsuoka, R. (2004) Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. Biochem. Biophys. Res. Commun. 325, 852-856
17. 2+ channel and ryanodine receptor signaling in hypertrophy. PLoS Biol. 5, e21
18. Landstrom, A. P., Weisleder, N., Batalden, K. B., Bos, J. M., Tester, D. J., Ommen, S. R., Wehrens, X. H., Claycomb, W. C., Ko, J. K., Hwang, M. et al. (2007) Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J. Mol. Cell Cardiol. 42, 1026-1035
19. Matsushita, Y., Furukawa, T., Kasanuki, H., Nishibatake, M., Kurihara, Y., Ikeda, A., Kamatani, N., Takeshima, H. and Matsuoka, R. (2007) Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy. J. Hum. Genet. 52, 543-548
20. Garbino, A., van Oort, R. J., Dixit, S. S., Landstrom, A. P., Ackerman, M. J. and Wehrens, X. H. (2009) Molecular evolution of the junctophilin gene family. Physiol. Genomics. 37, 175-186
21. Felder, E., Protasi, F., Hirsch, R., Franzini-Armstrong, C. and Allen, P. D. (2002) Morphology and molecular composition of sarcoplasmic reticulum surface junctions in the absence of DHPR and RyR in mouse skeletal muscle. Biophys. J. 82, 3144-3149
22. Guo, J., Sabri, A., Elouardighi, H., Rybin, V. and Steinberg, S. F. (2006) α1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes. Circ. Res. 99, 1367-1375
23. Molnar, A., Borbely, A., Czuriga, D., Ivetta, S. M., Szilagyi, S., Hertelendi, Z., Pasztor, E. T., Balogh, A., Galajda, Z., Szerafin, T. et al. (2009) Protein kinase C contributes to the maintenance of contractile force in human ventricular cardiomyocytes. J. Biol. Chem. 284, 1031-1039
24. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450
25. Lee, E. H., Rho, S. H., Kwon, S. J., Eom, S. H., Allen, P. D. and Kim, D. H. (2004) N-terminal region of FKBP12 is essential for binding to the skeletal ryanodine receptor. J. Biol. Chem. 279, 26481-26488
26. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev. 49, 1-51
27. 2+ permeability. Biochem. Pharmacol. 38, 3995-4003
28. 2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Cell Calcium 41, 295-302
29. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F. et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781
30. Cole, C., Barber, J. D. and Barton, G. J. (2008) The Jpred 3 secondary structure prediction server. Nucleic Acids Res. 36, W197-W201
31. Molkentin, J. D., Lu, J. R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R. and Olson, E. N. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (Pubitemid 28180855)
32. 2+ release channels: does diversity in form equal diversity in function? Physiol. Rev. 76, 1027-1071
33. 2+ release channel behavior of skeletal muscle. Biophys. J. 82, 1266-1277
34. Meissner, G. (2002) Regulation of mammalian ryanodine receptors. Front. Biosci. 7, d2072-2080
35. Song, L. S., Sobie, E. A., McCulle, S., Lederer, W. J., Balke, C. W. and Cheng, H. (2006) Orphaned ryanodine receptors in the failing heart. Proc. Natl. Acad. Sci. U.S.A. 103, 4305-4310
36. Gomez, A. M., Valdivia, H. H., Cheng, H., Lederer, M. R., Santana, L. F., Cannell, M. B., McCune, S. A., Altschuld, R. A. and Lederer, W. J. (1997) Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276, 800-806
37. 2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc. Natl. Acad. Sci. U.S.A. 106, 7636-7641
38. Nakayama, H., Wilkin, B. J., Bodi, I. and Molkentin, J. D. (2006) Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J. 20, 1660-1670
39. Onohara, N., Nishida, M., Inoue, R., Kobayashi, H., Sumimoto, H., Sato, Y., Mori, Y., Nagao, T. and Kurose, H. (2006) TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 25, 5305-5316
40. Brenner, J. S. and Dolmetsch, R. E. (2007) TrpC3 regulates hypertrophy-associated gene expression without affecting myocyte beating or cell size. PLoS ONE 2, e802
41. Bush, E. W., Hood, D. B., Papst, P. J., Chapo, J. A., Minobe, W., Bristow, M. R., Olson, E. N. and McKinsey, T. A. (2006) Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J. Biol. Chem. 281, 33487-33496
42. Palaniyandi, S. S., Sun, L., Ferreira, J. C. and Mochly-Rosen, D. (2009) Protein kinase C in heart failure: a therapeutic target? Cardiovasc. Res. 82, 229-239
43. Simonis, G., Briem, S. K., Schoen, S. P., Bock, M., Marquetant, R. and Strasser, R. H. (2007) Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy. Mol. Cell. Biochem. 305, 103-111